MTL
0.002
100%
4DS
0.01
-64.3%
KRR
0.011
57.1%
CZN
0.002
-33.3%
CHM
0.003
50%
TMK
0.002
-33.3%
LAT
0.065
38.3%
M4M
0.007
-22.2%
ANR
0.011
37.5%
QXR
0.004
-20%
AMS
0.012
33.3%
RC1
0.008
-20%
RNX
0.004
33.3%
SIS
0.004
-20%
SP3
0.032
33.3%
SPQ
0.004
-20%
CXU
0.009
28.6%
MGT
0.065
-18.8%
PEK
0.42
25.4%
THR
0.01
-16.7%
BYH
0.005
25%
VAR
0.005
-16.7%
FBR
0.005
25%
SNS
0.069
-15.9%
MRQ
0.005
25%
KCCDA
0.85
-15%
OEL
0.005
25%
EMU
0.023
-14.8%
XGL
0.028
21.7%
EM2
0.006
-14.3%
GML
0.063
21.2%
SPX
0.006
-14.3%
GLA
0.029
20.8%
WOA
0.013
-13.3%
BSN
0.047
20.5%
POD
0.04
-13%
MVL
0.018
20%
ESR
0.028
-12.5%
ZMM
0.018
20%
PET
0.007
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Partners with US based

BlinkLab (ASX:BB1) has initiated a clinical study in partnership with US based Turning Pointe Autism Foundation.

The data obtained during the course of this collaboration will be used to finalise the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.

BlinkLab is an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism.

Read the ASX announcement: https://yourir.info/resources/3449d9aa01a61c6b/announcements/bb1.asx/6A1205872/BB1_BlinkLab_Partnership_with_Turning_Pointe_Autism_Foundation.pdf #BB1